Is it safe for a patient taking Fioricet (butalbital 50 mg/acetaminophen 300 mg/caffeine 40 mg) to also take oxycodone 5 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Combining Fioricet with Oxycodone 5 mg: Safety Concerns

This combination requires extreme caution and should generally be avoided due to the significant risk of respiratory depression and overdose from combining butalbital (a barbiturate) with oxycodone (an opioid). 1, 2

Primary Safety Concern: Dangerous Drug Combination

The CDC explicitly warns against combining opioids with other central nervous system (CNS) depressants. While the guidelines specifically mention benzodiazepines, barbiturates like butalbital carry similar or greater risks 1, 2. Both butalbital and oxycodone depress respiratory drive, and their combined effect is additive or potentially synergistic for respiratory depression.

Key Risk Factors:

  • Butalbital is a barbiturate (not just a simple analgesic) with CNS depressant effects, habit-forming potential, and risk of dependence 3, 4
  • Concurrent use increases overdose risk through additive respiratory depression
  • Butalbital has significant withdrawal potential requiring careful monitoring if discontinuation is needed 4

Calculate Total Opioid Exposure

Using CDC conversion factors 2:

  • Oxycodone 5 mg = 7.5 MME (5 mg × 1.5 conversion factor)
  • If taken multiple times daily, this rapidly escalates total MME

The CDC recommends pausing and carefully reassessing when approaching ≥50 MME/day and emphasizes that many patients don't experience benefit beyond this threshold while facing progressive risk increases 2.

Clinical Decision Framework

If This Combination Is Already Prescribed:

  1. Review prescription drug monitoring program (PDMP) data immediately to identify if multiple prescribers are involved 1

  2. Calculate total daily MME from all opioid sources 1, 2

  3. Discuss safety concerns directly with the patient, specifically:

    • Increased respiratory depression risk
    • Signs of overdose to watch for
    • Never increase doses without medical supervision
    • Avoid alcohol and other sedatives completely
  4. Prescribe naloxone for overdose reversal, especially if:

    • Total MME ≥50/day
    • Any history of substance use disorder
    • Concurrent CNS depressants present 1
  5. Coordinate with all prescribers managing this patient to discuss risks and prioritize patient safety 1

Safer Alternatives to Consider:

The acetaminophen component in Fioricet (300 mg) could be combined with oxycodone/acetaminophen fixed-dose products instead, eliminating the barbiturate entirely 5, 6, 7. Research demonstrates that oxycodone 5 mg combined with acetaminophen 325 mg effectively manages moderate pain in 97% of patients 5.

Critical Pitfalls to Avoid:

  • Do not assume Fioricet is "just a headache medication" - it contains a controlled barbiturate with significant abuse and dependence potential 3, 4
  • Do not dismiss concerns about acetaminophen toxicity - total daily acetaminophen from all sources must not exceed 3000-4000 mg (Fioricet contains 300 mg per dose) 8
  • Do not abruptly discontinue either medication without medical supervision due to withdrawal risks 4

Bottom Line:

This combination significantly increases overdose risk and should prompt immediate prescriber communication to explore safer alternatives. If continuation is deemed absolutely necessary after risk-benefit assessment, implement all safety measures above including naloxone prescription, PDMP monitoring, and frequent reassessment 1, 2.

Related Questions

As the primary care physician for a female patient who had a renal stent placed two months ago, experienced complications, had a second stent placed and removed two weeks ago, and is currently taking oxycodone‑acetaminophen 5 mg/325 mg every 4–6 hours as needed (three 30‑tablet prescriptions), what is the appropriate management regarding additional pain medication after nephrology advised that her pain may improve over the next 4–6 weeks?
What is the recommended dose and duration of treatment for Percocet (oxycodone and acetaminophen)?
How should a patient's pain be managed with acetaminophen (1000mg every 8 hours), oxycodone (10mg every 4 hours as needed), and morphine (2mg IV every 4 hours as needed) for breakthrough pain?
What are the guidelines for prescribing medications that combine Tylenol (acetaminophen) and oxy (oxycodone) for pain management?
Can a patient take Robaxin (methocarbamol) and Percocet (oxycodone and acetaminophen) together?
What admitting diagnosis should be used for hospice admission of a patient with an undiagnosed neuromuscular disorder presenting with acute ascending paralysis?
What is the appropriate management for a pressure ulcer (bed sore) on the coccyx (tailbone)?
Is Vyvanse (lisdexamfetamine) ineffective when taken on an empty stomach with only coffee in the morning and only becoming effective after a protein‑rich lunch?
Is lymphoedema associated with restless legs syndrome (RLS)?
Are beta‑blockers contraindicated in patients with a heart rate in the 40 beats per minute range?
Does vaping a 5% nicotine e‑cigarette alter the efficacy or adverse effects of Vyvanse (lisdexamfetamine dimesylate) 60 mg in a patient who has been vaping since starting the medication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.